Skip to Content

NVR 7P5 (Afinitor 7.5 mg)

Generic Name: everolimus

Pill with imprint NVR 7P5 is White, Elliptical / Oval and has been identified as Afinitor 7.5 mg. It is supplied by Novartis Pharmaceuticals.

Afinitor is used in the treatment of neuroendocrine carcinoma; breast cancer; pancreatic cancer; renal angiomyolipoma; renal cell carcinoma (and more), and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Afinitor 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NVR 7P5

Afinitor 7.5 mg NVR 7P5

Afinitor

Generic Name:
everolimus
Imprint:
NVR 7P5
Strength:
7.5 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
MTOR inhibitors
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Novartis Pharmaceuticals
Inactive Ingredients:
butylated hydroxytoluene
crospovidone
hypromelloses
lactose anhydrous
lactose monohydrate
magnesium stearate
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide